Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Oncotelic Therapeutics Inc
OTLCCurrent price
0.029 USD
-0.0015 USD (-5.00%)
Last closed
0.028 USD
Company
www.oncotelic.com
ISIN
US6283411097
Sector
Healthcare
Industry
Biotechnology
Exchange
OTCQB
Capitalization
12 188 100 USD
Yield for 12 month
+5.56 %
1Y
3Y
5Y
10Y
15Y
OTLC
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. It develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes. The company also develops OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. In addition, it is developing CA4P for the treatment of advanced metastatic melanoma; intranasal drug and delivery system for intra-nasal Apomorphine for the treatment of Parkinson's Disease, erectile disfunction, and female sexual disfunction; Artemisinin, a natural derivative from an Asian herb Artemisia Annua; and AI based technologies to enhance the development and commercialization of support technologies. The company is headquartered in Agoura Hills, California. Address: 29397 Agoura Road, Agoura Hills, CA, United States, 91301
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4 USDP/E ratio
–Dividend Yield
–Current Year
+70 000 USD
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures OTLC
1 year
3 years
5 years
10 years
EBITDA
-552 028 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-0.76 %
PEG Ratio
–
Return On Equity TTM
-12.83 %
Wall Street Target Price
4 USD
Revenue TTM
70 000 USD
Book Value
0.03 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
1 740 855 USD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics OTLC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OTLC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:12
Payout Ratio
–
Last Split Date
28.12.2012
Dividend Date
–
Stock Valuation OTLC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
4.0258
Enterprise Value Revenue
370.5447
Price Sales TTM
174.1157
Enterprise Value EBITDA
2.6615
Price Book MRQ
1.1028
Financials OTLC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OTLC
For 52 weeks
0.017 USD
0.05 USD
50 Day MA
0.025 USD
Shares Short Prior Month
812 771
200 Day MA
0.034 USD
Short Ratio
8.04
Shares Short
662 753
Short Percent
2.5 %
BeatStart